Michelle LaracuenteApr 20, 20201 minReal-Time Pipeline Data... Beyond the Conference Presentation #Roche presented its late stage pipeline today at #JPM20, with #tecentriq heading up #oncology with six anticipated indications, includin...
Michelle LaracuenteApr 20, 20201 minCD-19 Antibody Making Waves at JPM2020A next generation CD-19 mAb, tafasitamab is all the buzz at #JPM2020! #Incyte acquired tafasitamab from #Morphosys, who had been developi...
Michelle LaracuenteJan 10, 20201 minKognitic Team to Hear from Industry Leaders at JPM2020#JPM2020 is right around the corner! The #Kognitic team is excited to hear from numerous industry leaders what is next for the pharma ind...
Michelle LaracuenteJan 9, 20201 minAmerican Cancer Society Releases Facts & Figures for 2019The American Cancer Society has released the cancer facts and figures for 2019. With almost 17 million Americans living with a history of...
Michelle LaracuenteJan 9, 20201 minKognitic Team Heads to JMP2020!Kognitic is excited to be heading to #JPM2020 to discuss the latest in innovative strategy for the pharma industry! Check out our website...
Michelle LaracuenteJan 7, 20201 minKognitic Honored by Healthcare Tech Outlook as a Top 10 Oncology Solution Provider for 2019!Thank you Healthcare Tech Outlook for featuring Kognitic in the Top Ten Oncology Companies of 2019. We are thrilled to be listed alongsid...
Michelle LaracuenteJan 7, 20201 minTargeting PD-L1: A New Front Runner for Oncology?A recent study has found that antibodies which target PD-L1 are more effective than PD-1 inhibitors at blocking PD-1/PD-L1 signaling (see...
Michelle LaracuenteJan 7, 20201 minCelebrating Amgen and the Lazarex Cancer Foundation's Support for Patient CareWe would like to celebrate Amgen’s partnership with the Lazarex Cancer Foundation, an organization which is dedicated to creating equitab...
Michelle LaracuenteJan 7, 20201 minLung Cancer Awareness DayIn honor of Lung Cancer Awareness Day (August 1st), we would like to call attention to assets currently in phase III for small cell lung ...
Michelle LaracuenteJan 7, 20201 minEli Lilly Pulls Away from Bispecific AntibodiesEli Lilly announced that it is pulling the plug on LY3415244, the company’s only bispecific antibody currently in pipeline (see attached ...
Michelle LaracuenteJan 7, 20201 minOpdivo Makes Waves in Colorectal CancerInteresting article about BMS expanding Opdivo's colorectal cancer indication. Which companies could be impacted by this expansion? Kogni...
Jaseem mahmmdlaAug 22, 20191 minLet's take a look at the Emerging Transformative Therapies around Key CancersThe number of emerging transformative therapy clinical trials are on the rise for the past few years. The therapies target multiple tumor...
Jaseem mahmmdlaAug 22, 20191 minImmunotherapy Combination Therapy InsightsNumber of industry sponsored clinical trials in immunotherapy over the past two years. Classification of Immunotherapy and the tumors the...
Jaseem mahmmdlaAug 22, 20192 minRevolutionizing Oncology LandscapesAutomation and new computer technologies are revolutionizing all industrial areas. Until a few years ago, developing a new product was ex...